Options Point to Further Drop for Cerebras Ahead of Q1
Put-heavy options ahead of after-hours Q1 results imply about a 12.7% further decline for Cerebras, which is down roughly 30% year-to-date.
Cerebras Systems shares face additional downside risk ahead of the company’s fiscal Q1 report after the market close today, based on options market pricing. Contracts expiring June 26 show a put-to-call ratio of about 1.75 and a lower strike near $187, which implies roughly a 12.7% drop by the end of the week if positions reflect market direction. The stock is down about 30% so far this year.
Options activity indicates heavier demand for puts than calls ahead of the after-hours release, signaling investors are seeking downside protection before the results.
Technical indicators point to near-term pressure. Shares fell below the 20-day moving average this morning. The relative strength index sits in the low 40s, below neutral and above commonly used oversold thresholds.
Cerebras trades at a price-to-sales ratio near 91 times current revenue estimates. Analysts polled ahead of the report expect a fiscal Q1 loss of about $0.14 per share and revenue near $57 million. The company reported roughly $510 million in revenue last year; the quarterly estimate reflects a slower revenue run rate compared with the prior year.
By comparison, Nvidia’s price-to-sales multiple sits near 23 times, illustrating a valuation gap between Cerebras and a sector leader.
Cerebras priced its IPO on May 14 at $185 per share and briefly traded above $380 before the stock fell in the weeks after the listing.
The company markets a monolithic WSE-3 processor designed to avoid bottlenecks associated with multi-chip systems. Engineers and customers have noted the processor’s theoretical compute advantages. Analysts are looking for evidence that those capabilities are converting into repeatable customer orders and sustained revenue growth.
Investors and analysts will watch the earnings release and the investor call this evening for details on customer contracts, sales visibility, plans to broaden the customer base and timelines for revenue scaling. Wall Street consensus shows an average price target near $289 and a “Strong Buy” rating for the stock.
Articles by this author
